Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Onartuzumab|DRUG: Bevacizumab|DRUG: Paclitaxel|DRUG: Bevacizumab Placebo|DRUG: Onartuzumab Placebo
Sponsor: Genentech, Inc.
Collaborators: Hoffmann-La Roche